Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

Affiliations

¹ Assistant Professor of Medicine, Johns Hopkins University, Baltimore, Maryland. Electronic address: mdiover1@jhmi.edu.
² Assistant Professor of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Attending physician, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Associate Professor of Pediatrics, University of Washington, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.
⁵ Assistant Professor of Medicine, University of Colorado, Denver, Colorado.
⁶ Professor, Fred Hutchinson Cancer Research Center, Associate Professor, University of Washington, Seattle, Washington.
⁷ Fred Hutchinson Cancer Center, Seattle, Washington; Professor of Medicine, University of Washington, Seattle, Washington.
⁸ Professor of Medicine, City of Hope, Duarte, California.
⁹ Associate Professor of Medicine, Weill Cornell Medical College, New York, New York; Memorial Sloan Kettering Cancer Center, New York, New York.
¹⁰ Memorial Sloan Kettering Cancer Center, New York, New York; Professor of Clinical Medicine, Weill Cornell Medical College, New York, New York.
¹¹ Professor of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
¹² Memorial Sloan Kettering Cancer Center, New York, New York; Professor of Medicine, Weill Cornell Medical College, New York, New York.

PMID: 36103987
PMCID: PMC9464362
DOI: 10.1016/j.jtct.2022.09.002

Practice Guideline

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

Veronica Dioverti et al. Transplant Cell Ther. 2022 Dec.

. 2022 Dec;28(12):810-821.

doi: 10.1016/j.jtct.2022.09.002. Epub 2022 Sep 11.

Authors

Affiliations

¹ Assistant Professor of Medicine, Johns Hopkins University, Baltimore, Maryland. Electronic address: mdiover1@jhmi.edu.
² Assistant Professor of Medicine, The Ohio State University Wexner Medical Center, Columbus, Ohio.
³ Attending physician, Memorial Sloan Kettering Cancer Center, New York, New York.
⁴ Associate Professor of Pediatrics, University of Washington, Seattle, Washington; Fred Hutchinson Cancer Center, Seattle, Washington.
⁵ Assistant Professor of Medicine, University of Colorado, Denver, Colorado.
⁶ Professor, Fred Hutchinson Cancer Research Center, Associate Professor, University of Washington, Seattle, Washington.
⁷ Fred Hutchinson Cancer Center, Seattle, Washington; Professor of Medicine, University of Washington, Seattle, Washington.
⁸ Professor of Medicine, City of Hope, Duarte, California.
⁹ Associate Professor of Medicine, Weill Cornell Medical College, New York, New York; Memorial Sloan Kettering Cancer Center, New York, New York.
¹⁰ Memorial Sloan Kettering Cancer Center, New York, New York; Professor of Clinical Medicine, Weill Cornell Medical College, New York, New York.
¹¹ Professor of Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
¹² Memorial Sloan Kettering Cancer Center, New York, New York; Professor of Medicine, Weill Cornell Medical College, New York, New York.

PMID: 36103987
PMCID: PMC9464362
DOI: 10.1016/j.jtct.2022.09.002

Abstract

This document is intended as a guide for diagnosis and management of Coronavirus Disease 2019 (COVID-19), caused by the virus SARS-CoV-2, in adult and pediatric HCT and cellular therapy patients. This document was prepared using available data and with expert opinion provided by members of the (ASTCT) Infectious Diseases Special Interest Group (ID-SIG) and is an update of pervious publication. Since our original publication in 2020, the NIH and IDSA have published extensive guidelines for management of COVID-19 which are readily accessible ( NIH Guidelines , IDSA Guidelines ). This update focuses primarily on issues pertaining specifically to HCT/cellular therapy recipients. Information provided in this manuscript may change as new information becomes available.

Keywords: COVID-19; Cellular therapy; Hematopoietic cell transplantation; SARS-CoV-2.

PubMed Disclaimer

References

1. Camargo JF, Mendoza MA, Lin R, et al. Clinical presentation and outcomes of COVID-19 following hematopoietic cell transplantation and cellular therapy. Transpl Infect Dis. 2021;23:e13625. - PMC - PubMed
1. Mushtaq MU, Shahzad M, Chaudhary SG, et al. Impact of SARS-CoV-2 in hematopoietic stem cell transplantation and chimeric antigen receptor T cell therapy recipients. Transplant Cell Ther. 2021;27:796. e1-.e7. - PMC - PubMed
1. Ljungman P, de la Camara R, Mikulska M, et al. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia. 2021;35:2885–2894. - PMC - PubMed
1. Sharma A, Bhatt NS, St Martin A, et al. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8:e185–e193. - PMC - PubMed
1. Waghmare A, Abidi MZ, Boeckh M, et al. Guidelines for COVID-19 management in hematopoietic cell transplantation and cellular therapy recipients. Biol Blood Marrow Transplant. 2020;26:1983–1994. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

K23 AG073534/AG/NIA NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

Affiliations

Revised Guidelines for Coronavirus Disease 19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients (August 2022)

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous